Working together to develop a screening platform to enhance the detection and management of Alzheimer’s disease.
PREDICTOM is an international across sector initiative to bring dementia diagnostics closer to the public through a customisable cognitive and biomarker screening platform.
Latest news
News
🤔 How Participants Move from Level 1 to Level 2 in PREDICTOM?
PREDICTOM applies a risk enrichment strategy to support scalable early detection of Alzheimer’s disease while ensuring that healthcare resources are deployed where they add most value. Movement from Level 1 to Level 2 is based on predictive risk modelling using routine primary care data, enabling population wide reach combined with targeted depth.
News
📄 At Home Alzheimer’s Detection Takes a Leap Forward
Imagine checking your brain health the way you check your blood pressure or sleep patterns—quickly, privately, and from the comfort of your own home. That vision is no longer futuristic speculation but the driving force behind PREDICTOM, a major European study that is quietly reshaping how Alzheimer’s disease might be detected long before symptoms appear.
News
🩺 Closing the Gap: Strengthening Europe’s Path to Timelier, Fairer Dementia Diagnosis
Have you ever wondered what happens when someone walks into their GP surgery worried about their memory - and whether that first step toward a dementia diagnosis looks the same across Europe?
PREDICTOM Study Progress
This page provides regularly updated information on the progress of the PREDICTOM study for everyone interested in following its development. The tracker will show progress for both Level 1 and Level 2 as the study advances.
Our mission
PREDICTOM will identify scalable biosignatures for early and accurate diagnosis of Alzheimer’s disease and personalized preventive interventions.